MedPath

Effect of Platelet-Rich Plasma (PRP) in the treatment of androgenic hair loss

Not Applicable
Recruiting
Conditions
Androgenic alopecia.
Androgenic alopecia
Registration Number
IRCT20160318027097N11
Lead Sponsor
Tabriz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
20
Inclusion Criteria

Age 18–60 years
Male pattern hair loss (MPHL)
Indication of the participant for PRP injection

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The androgenic alopecia clinical manifestations. Timepoint: Before the intervention, 2 weeks, 1 month, 3 months after the intervention. Method of measurement: Clinical examinations and dermoscopy.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath